CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 436962-437128 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"Rituximab appears safe in MS patients, and depleted circulating B cells with less robust effects on CSF B cells and IgG synthesis. [supported by NMSS USA, Genentech].","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T21374","span":{"begin":0,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T21374","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T55","span":{"begin":0,"end":166},"obj":"Sentence"}],"attributes":[{"subj":"T55","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1465","span":{"begin":100,"end":103},"obj":"Body_part"}],"attributes":[{"id":"A1465","pred":"uberon_id","subj":"T1465","obj":"http://purl.obolibrary.org/obo/UBERON_0001359"},{"subj":"T1465","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2969","span":{"begin":26,"end":28},"obj":"Disease"},{"id":"T67696","span":{"begin":26,"end":28},"obj":"Disease"}],"attributes":[{"id":"A2969","pred":"mondo_id","subj":"T2969","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A10272","pred":"mondo_id","subj":"T67696","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"subj":"T2969","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T67696","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#cdec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93e7"},{"id":"CORD-19-PD-UBERON","color":"#93ecd7"},{"id":"CORD-19-PD-MONDO","color":"#ecbd93"}]}]}}